INTERLEUKIN-6-ASSOCIATED LABORATORY PARAMETERS AND IMMUNOHISTOCHEMISTRY IN SYMPTOMATIC STAGE-A AND STAGE-B NODULAR SCLEROSING HODGKINS-DISEASE IN CHILDREN
Re. Brown et al., INTERLEUKIN-6-ASSOCIATED LABORATORY PARAMETERS AND IMMUNOHISTOCHEMISTRY IN SYMPTOMATIC STAGE-A AND STAGE-B NODULAR SCLEROSING HODGKINS-DISEASE IN CHILDREN, Annals of clinical and laboratory science, 27(1), 1997, pp. 26-33
Interleukin (IL)-6-associated laboratory parameters obtained at diagno
sis on 17 children with histologically confirmed nodular sclerosing Ho
dgkin's disease (NSHD) are reported. When these patients were grouped
as either symptomatic stage A or B, they were found to he similar in e
xtent of disease, age, and gender. However, statistically significant
differences between these two groups were observed for the means of th
e following IL-6-associated laboratory parameters: hematocrit (p = 0.0
19), platelet count (p = 0.009), serum albumin (p = 0.001), and ferrit
in (p = 0.037) concentrations. Moreover, trend analysis of abnormalcy
revealed an increasing frequency of anemia, thrombocytosis, hypoalbumi
nemia, and hyperferritinemia between stage A and B patients and, when
available, febrile controls (p values = 0.0012, 0.0009, 0.0406, and 0.
0011, respectively). Correspondingly, IL-6 immunohistochemistry perfor
med on archival material from representative cases in each group showe
d greater overall reactivity in specimens from stage B patients. A var
iety of cells accounted for this positivity for IL-6 antigen including
Reed-Sternberg cells and their variants, lacunar cells, dendritic int
erdigitating cells, endothelial cells, fibroblasts, and vascular smoot
h muscle cells. In summary, greater and more frequent abnormalities in
IL-6-associated laboratory parameters and increased immunohistochemic
al reactivity for IL-6 antigen coincide with the presence of fever in
helping to identify children with clinical stage B NSHD.